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Background
Undifferentiated high-grade pleomorphic sarcomas (UPS)
display an aggressive clinical behavior with frequent
development of distant metastasis and local recurrence.
Since these tumors, particularly leiomyosarcomas (LMS),
present a similar morphological pattern with other enti-
ties, the classification criterion by exclusion is frequently
used.
Methodology
In this study, array-based comparative genomic hybridi-
zation (array CGH) was applied in 20 UPS and 17 LMS
(untreated cases). Array CGH (Agilent Technologies,
44K) data were analyzed by Nexus Software (v 6.0,
BioDiscovery). Multivariate analysis was performed in
order to identify the most important prognostic factors.
Results
LMS presented lower frequency of genomic alterations in
comparison with UPS. None of the variables were identi-
fied as independent prognostic factors, but gains at 1q21.3
were significantly associated with poor survival and showed
almost significance as an independent prognostic factor
(relative risk 13.8, P = 0.019). In addition, copy number
profile of UPS and LMS was indistinguishable by unsuper-
vised hierarchical clustering analysis, one out of three clus-
ters presented cases associated with poor prognosis (P =
0.022). Relative copy number analysis for ARNT, SLC27A3,
PBXIP1 and CCND1 genes was performed by quantitative
real time PCR in 11 LMS and 16 UPS confirming the array
CGH findings. Gains on 1q21-q22 involving ARNT, PXIP1
and SCL27A3 were observed exclusively in a subset of UPS.
Conclusions
These findings describing a poor prognosis genomic signa-
ture in a subgroup of UPS and LMS can contribute to
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